⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL575832 | 0.72 | — | — | |
| SCHEMBL127573 | 0.72 | — | — | |
| SCHEMBL6366452 | 0.71 | — | — | |
| SCHEMBL2719219 | 0.69 | — | — | |
| SCHEMBL1744592 | 0.69 | — | — | |
| SCHEMBL7904054 | 0.69 | — | — | |
| SCHEMBL118543 | 0.67 | — | — | |
| SCHEMBL3218486 | 0.67 | — | — | |
| SCHEMBL6120042 | 0.67 | — | — | |
| SCHEMBL3218494 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9751865-B2 | Dihydro-hydantoin derivatives with herbicidal activity | SYNGENTA LIMITED (GB) | 2017-09-05 | — | — | US | disclosed |
| US-9605004-B2 | Chemical compounds | SYNGENTA LIMITED (GB) | 2017-03-28 | — | — | US | disclosed |
| US-20160318906-A1 | DIHYDRO-HYDANTOIN DERIVATIVES WITH HERBICIDAL ACTIVITY | SYNGENTA LIMITED (GB) | 2016-11-03 | — | — | US | disclosed |
| US-20160168126-A1 | CHEMICAL COMPOUNDS | SYNGENTA LIMITED (GB) | 2016-06-16 | — | — | US | disclosed |
| US-20160159819-A1 | CHEMICAL COMPOUNDS | SYNGENTA LIMITED (GB) | 2016-06-09 | — | — | US | disclosed |
| WO-2015018433-A1 | PYRAZOLYL PYRROLINONES AND THEIR USE AS HERBICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2015-02-12 | — | — | WO | disclosed |
| WO-2015018434-A1 | PYRAZOLYL PYRROLINONES AND THEIR USE AS HERBICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2015-02-12 | — | — | WO | disclosed |
| US-8143237-B2 | Anti-cancer drugs, and uses relating for malignant melanoma and other cancers | KASINA LAILA INNOVA PHARMACEUTICALS PRIVATE LIMITED (US) | 2012-03-27 | — | — | US | disclosed |
| US-20100272678-A1 | ANTI-CANCER DRUGS, AND USES RELATING FOR MALIGNANT MELANOMA AND OTHER CANCERS | KASINA LAILA INNOVA PHARMACEUTICALS PRIVATE LIMITE (IN) | 2010-10-28 | — | — | US | disclosed |
| EP-0986382-B1 | RAF KINASE INHIBITORS | BAYER PHARMACEUTICALS CORP (US) | 2008-06-25 | — | — | EP | disclosed |
| US-4711954-A | FOR POLYAMIDES; COLORFASTNESS | BAYER AKTIENGESELLSCHAFT (DE) | 1987-12-08 | — | — | US | disclosed |